查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型和最终用户
市场调查报告书
商品编码
1375183

北美器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型和最终用户

North America Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, Organ Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 146 Pages | 订单完成后即时交付

价格

北美器官保存解决方案市场预计将从2023年的1.2036亿美元成长到2028年的1.7718亿美元。预计2023年至2028年的复合年增长率为8.0%。

导致肾衰竭的慢性病盛行率不断增加，推动北美器官保存解决方案市场成长

肾臟移植是全球最常见的器官移植。根据器官采购和移植网络（OPTN）的数据，2021年美国进行了41,354例器官移植，比2020年增长5.9%。其中肾臟移植总数为24,669例，肝臟移植总数为9,236例，心臟移植总数为3,817例。

慢性肾臟病 (CKD) 是一种常见且可能致命的疾病，影响全球大约每十个人中就有一个。此外，美国国家肾臟基金会发表的一项研究预测，20岁以上的糖尿病族群随着时间的推移将患上慢性肾病。

美国国家肾臟基金会报告称，预计 2021 年 CKD 导致的死亡人数将超过前列腺癌或乳腺癌。这是一种未被广泛认识的紧急健康状况。

根据美国疾病管制与预防中心 (CDC) 2020 年的估计，三分之一的糖尿病成人和五分之一的高血压成人可能患有慢性肾臟病。根据 CDC 2021 年发布的报告，美国每年约有 15% 的人患有慢性肾臟病。

国家肾臟基金会表示，肾臟受损的人并不知道患有慢性肾臟疾病，这显示肾臟疾病市场的潜在市场潜力。预计这些因素将在预测期内促进市场成长。

北美器官保存解决方案市场概况

基于美国、加拿大和墨西哥三个主要国家对北美器官保存解决方案市场进行分析。由于器官移植的增加和老年人口的增加等因素，美国在器官保存解决方案市场中占有最大份额。

在北美，美国是器官保存解决方案的最大市场。美国慢性肾臟病盛行率的增加和老年人口的增加可能会加速该市场的发展。例如，根据国家慢性肾臟病情况说明书，2021 年，美国约有 3,700 万人患有慢性肾臟病。此外，根据美国肾臟基金会的数据，约有81万美国人患有肾衰竭，其中57万名患者正在接受透析，24万名患者接受了肾臟移植。此外，根据 CDC 的数据，慢性肾臟病 (CKD) 在 65 岁或以上人群 (38%) 中比 45-64 岁人群 (12%) 或 18-44 岁人群 (6%) 更常见。尊重当前的估计。此外，随着 CKD 在美国的盛行率不断增加，与 CKD 相关的健康问题随着时间的推移而恶化。它还会增加心臟病和中风的机会。因此，由于这些事实，未来几年肾臟移植病例可能会增加。此外，FDA 批准的增加以及该地区主要市场参与者的存在正在推动市场成长。例如，2022 年 4 月，TransMedics Group, Inc. 的 OCS 心臟系统获得了美国食品药物管理局 (FDA) 的上市前批准，可用于循环死亡 (DCD) 捐赠者的器官。

北美器官保存解决方案市场收入及2028年预测（百万美元）

北美器官保存解决方案市场细分

北美器官保存解决方案市场按类型、应用、器官类型、最终用户和国家进行细分。

根据类型，北美器官保存溶液市场分为威斯康辛大学溶液、custodiol htk、perfadex、hyperthermosol 等。威斯康辛大学解决方案部门于 2023 年占据北美器官保存解决方案市场份额最大的份额。

根据应用，北美器官保存解决方案市场分为静态冷藏、低温机器灌注、常温机器灌注等。 2023 年，静态冷藏领域占据北美器官保存解决方案最大市场。

根据器官类型，北美器官保存解决方案市场分为肾臟、肝臟、肺臟、心臟等。 2023 年，肾臟细分市场占据北美最大的器官保存解决方案市场。

根据最终用户，北美器官保存解决方案市场分为器官移植中心、医院和专科诊所。到 2023 年，器官移植中心细分市场将占据北美器官保存解决方案最大的市场。

按国家划分，北美器官保存解决方案市场分为美国、加拿大和墨西哥。 2023年，美国在北美器官保存解决方案市场份额中占据主导地位。

21世纪医学；雅阁医疗保健；生命之桥有限公司； Franz Koehler Chemie GmbH 博士；生命线科学公司；有机氧化有限公司； Paragonix 技术公司；保存解决方案公司；跨医疗机构；沃特世医疗系统有限责任公司；和 XVIVO Perfusion 是该地区北美器官保存解决方案市场的领导公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 北美器官保存解决方案市场 - 按类型
    • 北美器官保存解决方案市场 - 按应用
    • 北美器官保存解决方案市场 - 按器官类型
    • 北美器官保存解决方案市场 - 按最终用户划分
    • 北美器官保存解决方案市场 - 按国家/地区

第 2 章：北美器官保存解决方案市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美器官保存解决方案市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 - PEST 分析
  • 专家意见

第 5 章：北美器官保存解决方案市场 - 主要市场动态

  • 市场驱动因素
    • 器官移植的需求不断增加
    • 导致肾衰竭的慢性病盛行率不断增加
    • 老年人口增加
  • 市场限制
    • 昂贵的器官移植手术
    • 器官移植手术捐赠者数量有限
  • 市场机会
    • 心血管疾病 (CVD) 盛行率上升
  • 未来的趋势
    • 新兴国家的成长机会
  • 影响分析

第 6 章：器官保存解决方案市场 - 北美分析

  • 北美器官保存解决方案市场收入预测与分析

第 7 章：北美器官保存解决方案市场 - 2028 年收入与预测 - 按类型

  • 概述
  • 威斯康辛大学解决方案 (UW) 市场
  • 保管二醇 HTK
  • 佩法迪克斯
  • 低温溶胶
  • 其他的

第 8 章：北美器官保存解决方案市场 - 2028 年收入和预测 -按应用

  • 概述
  • 2022 年和 2028 年北美器官保存解决方案市场份额，按应用划分 (%)
  • 静态冷库
  • 低温灌注机
  • 常温机器灌注
  • 其他的

第 9 章：北美器官保存解决方案市场 - 2028 年收入和预测 - 按器官类型

  • 概述
  • 2022 年和 2028 年北美器官保存解决方案市场份额，按器官类型划分（%）
  • 心
  • 肺
  • 肾
  • 肝
  • 其他的

第 10 章：北美器官保存解决方案市场 - 收入和 2028 年预测 - 按最终用户

  • 概述
  • 2022 年和 2028 年北美器官保存解决方案市场份额（按最终用户）（%）
  • 器官移植中心
  • 医院
  • 专科诊所

第 11 章：北美器官保存解决方案市场 - 2028 年收入与预测 - 国家分析

  • 北美：器官保存解决方案市场
    • 概述

第 12 章：北美器官保存解决方案市场-产业格局

  • 概述
  • 器官保存解决方案市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章：公司简介

  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • TransMedics
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • ST CENTURY MEDICINE
  • Bridge to Life Ltd
  • Preservation Solutions, Inc.
  • Lifeline Scientific, Inc.

第 14 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: TIPRE00025778

The North America organ preservation solutions market is expected to grow from US$ 120.36 Million in 2023 to US$ 177.18 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Leading to Kidney Failure Fueling North America Organ Preservation Solutions Market Growth

A kidney transplant is the most common organ transplant globally. According to the Organ Procurement and Transplantation Network (OPTN), in 2021, 41,354 organ transplants were performed in the US, an increase of 5.9% over 2020. There were a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants.

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately one in every ten people worldwide. Additionally, a study published by the National Kidney Foundation predicted that the diabetic population over the age of 20 would develop chronic kidney disease over time.

The National Kidney Foundation reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition.

According to the estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. According to the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

The National Kidney Foundation states that people with kidney damage are unaware of having chronic kidney disease, which indicates the underlying market potential in the kidney disease market. These factors are expected to enhance market growth during the forecast period.

North America Organ Preservation Solutions Market Overview

The North America organ preservation solution market is analyzed based on three major countries: the US, Canada, and Mexico. The US holds the largest share of the organ preservation solution market owing to factors such as the increasing organ transplantation and growing geriatric population.

In North America, the US is the largest market for organ preservation solutions. Increasing prevalence of chronic kidney diseases and growing geriatric population in the US are likely to accelerate the development of this market. For instance, according to the National Chronic Kidney Disease fact sheet, in 2021, ~37 million people had chronic kidney diseases in the US. Furthermore, according to the American Kidney Fund, Inc, ~810,000 Americans have kidney failure, of which 570,000 patients are undergoing dialysis, and 240,000 have undergone kidney transplantation. In addition, according to the CDC, chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) with respect to the current estimate. Moreover, with the increasing prevalence of CKD in the US, CKD-related health problems worsen over time. It also increases the chances of having heart disease and stroke. Thus, owing to these facts, the cases of kidney transplantations are likely to increase in the coming years. Moreover, the rise in FDA approvals and the presence of the major market players in the region are boosting the market growth. For instance, in April 2022, TransMedics Group, Inc. received premarket U.S. Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD).

North America Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is segmented into type, application, organ type, end user, and country.

Based on type, the North America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest North America organ preservation solution market share in 2023.

Based on application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest North America organ preservation solution market share in 2023.

Based on organ type, the North America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest North America organ preservation solution market share in 2023.

Based on end user, the North America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest North America organ preservation solution market share in 2023.

Based on country, the North America organ preservation solutions market has been categorized into the US, Canada, and Mexico. The US dominated the North America organ preservation solutions market share in 2023.

21ST CENTURY MEDICINE; Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are the leading companies operating in the North America organ preservation solutions market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organ preservation solution market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Organ Preservation Solution Market - by Type
    • 1.3.2 North America Organ Preservation Solution Market - by Application
    • 1.3.3 North America Organ Preservation Solution Market - by Organ Type
    • 1.3.4 North America Organ Preservation Solution Market - by End User
    • 1.3.5 North America Organ Preservation Solution Market - by Country

2. North America Organ Preservation Solution Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Organ Preservation Solution Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
  • 4.3 Expert Opinions

5. North America Organ Preservation Solution Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Need for Organ Transplantation
    • 5.1.2 Increasing Prevalence of Chronic Diseases Leading to Kidney Failure
    • 5.1.3 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Expensive Organ Transplant Surgeries
    • 5.2.2 Limited Number of Donors for Organ Transplant Surgeries
  • 5.3 Market Opportunities
    • 5.3.1 Rising Prevalence of Cardiovascular Diseases (CVDs)
  • 5.4 Future Trends
    • 5.4.1 Growth Opportunities in Emerging Nations
  • 5.5 Impact Analysis

6. Organ Preservation Solution Market - North America Analysis

  • 6.1 North America Organ Preservation Solutions Market Revenue Forecast and Analysis

7. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
    • 7.1.1 North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • 7.2 University of Wisconsin Solution (UW) Market
    • 7.2.1 Overview
    • 7.2.2 University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.3 Custodiol HTKs
    • 7.3.1 Overview
    • 7.3.2 Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.4 Perfadex
    • 7.4.1 Overview
    • 7.4.2 Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.5 Hypothermosol
    • 7.5.1 Overview
    • 7.5.2 Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)

8. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 North America Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
  • 8.3 Static Cold Storage
    • 8.3.1 Overview
    • 8.3.2 Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.4 Hypothermic Machine Perfusion
    • 8.4.1 Overview
    • 8.4.2 Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.5 Normothermic Machine Perfusion
    • 8.5.1 Overview
    • 8.5.2 Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)

9. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Organ Type

  • 9.1 Overview
  • 9.2 North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • 9.3 Heart
    • 9.3.1 Overview
    • 9.3.2 Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.4 Lung
    • 9.4.1 Overview
    • 9.4.2 Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.5 Kidney
    • 9.5.1 Overview
    • 9.5.2 Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.6 Liver
    • 9.6.1 Overview
    • 9.6.2 Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

10. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by End User

  • 10.1 Overview
  • 10.2 North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • 10.3 Organ Transplant Centres
    • 10.3.1 Overview
    • 10.3.2 Organ Transplant Centres : North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.5 Specialty Clinics
    • 10.5.1 Overview
    • 10.5.2 Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

11. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 -Country Analysis

  • 11.1 North America: Organ Preservation Solution Market
    • 11.1.1 Overview
      • 11.1.1.1 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.3 United States: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.4 United States: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.1.5 United States: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.6 United States: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.3 Canada: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.4 Canada: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.2.5 Canada: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.6 Canada: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.3 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.3 Mexico: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.4 Mexico: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.3.5 Mexico: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.6 Mexico: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)

12. North America Organ Preservation Solution Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Organ Preservation Solutions Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Waters Medical Systems LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 XVIVO Perfusion
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 TransMedics
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 OrganOx Limited
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Paragonix Technologies, Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Dr. Franz Koehler Chemie GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Accord Healthcare
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8ST CENTURY MEDICINE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bridge to Life Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Preservation Solutions, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Lifeline Scientific, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. United States Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 2. United States Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 3. United States Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 4. United States Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 5. Canada Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 6. Canada Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 7. Canada Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 8. Canada Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 9. Mexico Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 10. Mexico Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 11. Mexico Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 12. Mexico Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 13. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 14. Recent Organic Growth Strategies in the Organ Preservation Solutions Market
  • Table 15. Glossary of Terms

List Of Figures

  • Figure 1. North America Organ Preservation Solution Market Segmentation
  • Figure 2. North America Organ Preservation Solution Market, by region
  • Figure 3. North America Organ Preservation Solution Market Overview
  • Figure 4. University of Wisconsin solution (UW) Segment Held Largest Share of Type Segment in North America Organ Preservation Solution Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America PEST Analysis
  • Figure 7. North America Organ Preservation Solutions Market Impact Analysis of Drivers and Restraints
  • Figure 8. North America Organ Preservation Solutions Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 9. North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • Figure 10. University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 11. Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 12. Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 13. Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 14. Others: North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 15. Medical devices market Share, by Application, 2022 and 2028 (%)
  • Figure 16. Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 17. Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 18. Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 19. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 20. North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • Figure 21. Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 22. Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 23. Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 24. Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 25. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 26. North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • Figure 27. Organ Transplant Centers: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 28. Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 29. Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 30. North America: Organ Preservation Solution Market, by Key Country - Revenue (2022) (US$ Thousand)
  • Figure 31. North America: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
  • Figure 32. United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 33. Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 34. Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 35. Growth Strategies in the Organ Preservation Solutions Market